drugset / Trial / NCT00004422

Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection

NCT00004422 ↗

Phase 3 Completed 174 enrolled IWK Health Centre
RandomizedTreatment

Summary

OBJECTIVES: Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.

Timeline

Start
1997-08
Primary completion
—
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject pertussis immune globulin Unknown — Intravenous

Indications